BioVentrix

BioVentrix is a private medical device company that focuses on developing minimally invasive therapies to treat left ventricular (LV) failure. BioVentrix technology aims to improve cardiac function by directly addressing left ventricular dilation. The company is preparing to submit a PMA application to the U.S. Food and Drug Administration later this year.